Showing results (71-80 of 75) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Therapeutic Advances in Medical Oncology|March 16, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter studyTaha Koray Sahin, Fatih Kemik, Harun Muglu, et al.Journal of Clinical Medicine|February 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective AnalysisBaris Koksal, Hasan Cagri Yildirim, Deniz Can Guven, et al.Current Oncology (Toronto, Ont.)|June 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) StudyMustafa Seyyar, Ali Kalem, Mürsel Sali, et al.Updates in Surgery|April 11, 2021
Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical optionsOrhan Agcaoglu, Atakan Sezer, Ozer Makay, et al.International Journal of Cancer|October 28, 2025
Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology GroupSalih Tunbekici, Gokhan Sahin, Sercan Ön, et al.Pageof 8